4-HO-pyr-T

4-HO-pyr-T
Clinical data
Other names4-OH-pyr-T; 4-Hydroxy-pyr-tryptamine; 4-Hydroxy-N,N-tetramethylenetryptamine; 1-[2-[3-(4-Hydroxy)indolyl]ethyl]pyrrolidine; 4-Hydroxypyrrolidyltryptamine; 3-[2-(1-Pyrrolidyl)ethyl]-4-indolol
Drug classSerotonin receptor modulator
ATC code
  • None
Identifiers
  • 3-[2-(pyrrolidin-1-yl)ethyl]-1H-indol-4-ol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H18N2O
Molar mass230.311 g·mol−1
3D model (JSmol)
  • Oc2cccc3[nH]cc(CCN1CCCC1)c23
  • InChI=1S/C14H18N2O/c17-13-5-3-4-12-14(13)11(10-15-12)6-9-16-7-1-2-8-16/h3-5,10,15,17H,1-2,6-9H2 Y
  • Key:XASLPZWIPBCAPF-UHFFFAOYSA-N Y
  (verify)

4-HO-pyr-T, also known as 4-hydroxy-N,N-tetramethylenetryptamine, is a serotonin receptor modulator of the tryptamine, 4-hydroxytryptamine, and pyrrolidinylethylindole families. It is the 4-hydroxyl analogue of pyr-T and the analogue of psilocin (4-HO-DMT) and 4-HO-DET in which the N,N-dialkyl moiety has been cyclized into a pyrrolidine ring.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.